Environmental, Social And Governance Report

Overview

The report covers Agios Pharmaceuticals' 2019 ESG disclosures and describes initiatives spanning patients, employees, communities and ethical business practices. It highlights approximately 550 employees and 2019 revenue of $118 M. Patient-access efforts included a robust assistance program, free drug provision for about 20% of TIBSOVO demand, and an expanded access program. ESG and sustainability updates were explicitly provided to the Board of Directors.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2020
Period: 1 January 2019 – 31 December 2019
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services